Patent details

Basic Information

Publication number:

LUC50033

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP158042101

Legal Status:

Pending & Published

Application number:

LUC50033

First applicant's nationality:

Procedural language:

English

Marketing Authorization

Marketing Authorization Number:

EU/1/25/1975

Marketing Authorization Type:

Marketing Authorization Date:

18/09/2025

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

12/01/2026

First Marketing Authorization date:

18/09/2025

Grant date:

Activation date:

Publication date:

13/01/2026

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

18/09/2040

SPC Extension Expiration:

18/09/2040

Rejection date:

Withdrawal date:

Owner

From:

12/01/2026

 

 

Name:

Kalvista Pharmaceuticals Limited

Address:

Porton Science Park Bybrook Road, Porton Down Wiltshire SP4 0BF, United Kingdom (GB)

Agent

1

Name:

Dennemeyer & Associates S.A.

From:

12/01/2026

Address:

55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)

To:

2

Name:

Dennemeyer & Associates München / Rolf Klemm

From:

12/01/2026

Address:

Bavariastr.7, 80336, MÜNCHEN, Unknown (UNKNOWN)

To:

13/01/2026

Publication

Bulletin

Bulletin Heading:

SPC1

Bulletin edition number:

2026/03

Publication date:

05/02/2026

Description:

Section C : Published requests for Supplementary Protection Certificates – I1 publication

Annual Fees

Annual Fee Due Date:

30/11/2035

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
12/01/2026	Application Form	5
12/01/2026	Outgoing Correspondence	2
12/01/2026	General Document	1
12/01/2026	General Document	27
12/01/2026	General Document	3
12/01/2026	General Document	1
13/01/2026	Outgoing Correspondence	1
13/01/2026	Publication	1
12/01/2026	MA publication	11